FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2792218617> ?p ?o ?g. }

• W2792218617 abstract "ABSTRACT Direct interactions between bacterial and host glycans have been recently reported to be involved in the binding of pathogenic bacteria to host cells. In the case of Shigella , the Gram-negative enteroinvasive bacterium responsible for acute rectocolitis, such interactions contribute to bacterial adherence to epithelial cells. However, the role of glycans in the tropism of Shigella for immune cells whose glycosylation pattern varies depending on their activation state is unknown. We previously reported that Shigella targets activated, but not nonactivated, human CD4 + T lymphocytes. Here, we show that nonactivated CD4 + T lymphocytes can be turned into Shigella -targetable cells upon loading of their plasma membrane with sialylated glycosphingolipids (also termed gangliosides). The Shigella targeting profile of ganglioside-loaded nonactivated T cells is similar to that of activated T cells, with a predominance of injection of effectors from the type III secretion system (T3SS) not resulting in cell invasion. We demonstrate that gangliosides interact with the O-antigen polysaccharide moiety of lipopolysaccharide (LPS), the major bacterial surface antigen, thus promoting Shigella binding to CD4 + T cells. This binding step is critical for the subsequent injection of T3SS effectors, a step which we univocally demonstrate to be dependent on actin polymerization. Altogether, these findings highlight the critical role of glycan-glycan interactions in Shigella pathogenesis. IMPORTANCE Glycosylation of host cell surface varies with species and location in the body, thus contributing to species specificity and tropism of microorganisms. Cross talk by Shigella , the Gram-negative enteroinvasive bacterium responsible for bacillary dysentery, with its exclusively human host has been extensively studied. However, the molecular determinants of the step of binding to host cells are poorly defined. Taking advantage of the observation that human-activated CD4 + T lymphocytes, but not nonactivated cells, are targets of Shigella , we succeeded in rendering the refractory cells susceptible to targeting upon loading of their plasma membrane with sialylated glycosphingolipids (gangliosides) that are abundantly present on activated cells. We show that interactions between the sugar polar part of gangliosides and the polysaccharide moiety of Shigella lipopolysaccharide (LPS) promote bacterial binding, which results in the injection of effectors via the type III secretion system. Whereas LPS interaction with gangliosides was proposed long ago and recently extended to a large variety of glycans, our findings reveal that such glycan-glycan interactions are critical for Shigella pathogenesis by driving selective interactions with host cells, including immune cells." @default.
• W2792218617 created "2018-03-29" @default.
• W2792218617 creator A5016327665 @default.
• W2792218617 creator A5021345052 @default.
• W2792218617 creator A5024504530 @default.
• W2792218617 creator A5029432856 @default.
• W2792218617 creator A5031417794 @default.
• W2792218617 creator A5033744969 @default.
• W2792218617 creator A5052807201 @default.
• W2792218617 creator A5061724342 @default.
• W2792218617 creator A5069666784 @default.
• W2792218617 creator A5077793315 @default.
• W2792218617 creator A5082736960 @default.
• W2792218617 date "2018-03-07" @default.
• W2792218617 modified "2023-10-14" @default.
• W2792218617 title "Glycan-Glycan Interaction Determines <i>Shigella</i> Tropism toward Human T Lymphocytes" @default.
• W2792218617 cites W1907467297 @default.
• W2792218617 cites W1991245510 @default.
• W2792218617 cites W1997351842 @default.
• W2792218617 cites W2003570753 @default.
• W2792218617 cites W2004152924 @default.
• W2792218617 cites W2006391403 @default.
• W2792218617 cites W2007012258 @default.
• W2792218617 cites W2016435585 @default.
• W2792218617 cites W2041898898 @default.
• W2792218617 cites W2043633916 @default.
• W2792218617 cites W2051038445 @default.
• W2792218617 cites W2075028497 @default.
• W2792218617 cites W2092296126 @default.
• W2792218617 cites W2099344126 @default.
• W2792218617 cites W2100412095 @default.
• W2792218617 cites W2111553815 @default.
• W2792218617 cites W2124028434 @default.
• W2792218617 cites W2133013758 @default.
• W2792218617 cites W2145307623 @default.
• W2792218617 cites W2145640886 @default.
• W2792218617 cites W2150312794 @default.
• W2792218617 cites W2151889957 @default.
• W2792218617 cites W2151988974 @default.
• W2792218617 cites W2153543093 @default.
• W2792218617 cites W2156061256 @default.
• W2792218617 cites W2170644493 @default.
• W2792218617 cites W2204314377 @default.
• W2792218617 cites W2620955321 @default.
• W2792218617 cites W2747084047 @default.
• W2792218617 cites W977592614 @default.
• W2792218617 doi "https://doi.org/10.1128/mbio.02309-17" @default.
• W2792218617 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5821077" @default.
• W2792218617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29440574" @default.
• W2792218617 hasPublicationYear "2018" @default.
• W2792218617 type Work @default.
• W2792218617 sameAs 2792218617 @default.
• W2792218617 citedByCount "24" @default.
• W2792218617 countsByYear W27922186172018 @default.
• W2792218617 countsByYear W27922186172019 @default.
• W2792218617 countsByYear W27922186172020 @default.
• W2792218617 countsByYear W27922186172021 @default.
• W2792218617 countsByYear W27922186172022 @default.
• W2792218617 countsByYear W27922186172023 @default.
• W2792218617 crossrefType "journal-article" @default.
• W2792218617 hasAuthorship W2792218617A5016327665 @default.
• W2792218617 hasAuthorship W2792218617A5021345052 @default.
• W2792218617 hasAuthorship W2792218617A5024504530 @default.
• W2792218617 hasAuthorship W2792218617A5029432856 @default.
• W2792218617 hasAuthorship W2792218617A5031417794 @default.
• W2792218617 hasAuthorship W2792218617A5033744969 @default.
• W2792218617 hasAuthorship W2792218617A5052807201 @default.
• W2792218617 hasAuthorship W2792218617A5061724342 @default.
• W2792218617 hasAuthorship W2792218617A5069666784 @default.
• W2792218617 hasAuthorship W2792218617A5077793315 @default.
• W2792218617 hasAuthorship W2792218617A5082736960 @default.
• W2792218617 hasBestOaLocation W27922186171 @default.
• W2792218617 hasConcept C104317684 @default.
• W2792218617 hasConcept C108625454 @default.
• W2792218617 hasConcept C153911025 @default.
• W2792218617 hasConcept C159047783 @default.
• W2792218617 hasConcept C203014093 @default.
• W2792218617 hasConcept C206212055 @default.
• W2792218617 hasConcept C2522874641 @default.
• W2792218617 hasConcept C2776986154 @default.
• W2792218617 hasConcept C2777313579 @default.
• W2792218617 hasConcept C2778754761 @default.
• W2792218617 hasConcept C2780610775 @default.
• W2792218617 hasConcept C2781065037 @default.
• W2792218617 hasConcept C2781217973 @default.
• W2792218617 hasConcept C35693153 @default.
• W2792218617 hasConcept C49039625 @default.
• W2792218617 hasConcept C51785407 @default.
• W2792218617 hasConcept C523546767 @default.
• W2792218617 hasConcept C54355233 @default.
• W2792218617 hasConcept C547475151 @default.
• W2792218617 hasConcept C55493867 @default.
• W2792218617 hasConcept C86803240 @default.
• W2792218617 hasConcept C89423630 @default.
• W2792218617 hasConcept C95444343 @default.
• W2792218617 hasConceptScore W2792218617C104317684 @default.
• W2792218617 hasConceptScore W2792218617C108625454 @default.
• W2792218617 hasConceptScore W2792218617C153911025 @default.
• W2792218617 hasConceptScore W2792218617C159047783 @default.
• W2792218617 hasConceptScore W2792218617C203014093 @default.

• next